Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97%
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Panacea Biotec Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Interest Income Expense
-â‚ą35.2m
CAGR 3-Years
74%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Interest Income Expense
-â‚ą75.3m
CAGR 3-Years
-16%
CAGR 5-Years
-55%
CAGR 10-Years
-11%
Transgene Biotek Ltd
BSE:526139
Interest Income Expense
-â‚ą991k
CAGR 3-Years
26%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Interest Income Expense
â‚ą0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Interest Income Expense
-â‚ą165.2m
CAGR 3-Years
-54%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Interest Income Expense
-â‚ą9.8B
CAGR 3-Years
-54%
CAGR 5-Years
-76%
CAGR 10-Years
-65%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Interest Income Expense?
Interest Income Expense
-35.2m INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Interest Income Expense amounts to -35.2m INR.

What is Panacea Biotec Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
52%

Over the last year, the Interest Income Expense growth was 10%. The average annual Interest Income Expense growth rates for Panacea Biotec Ltd have been 74% over the past three years , 52% over the past five years .

Back to Top